Trial finds monoclonal antibody therapy improves survival in cancer-associated hyper-inflammatory disorder
Adult patients with newly diagnosed malignancy-associated hemophagocytic lymphohistiocytosis (mHLH)—a rare, aggressive ...
Rolling Out1d
New COVID-19 treatments bring hope to at-risk communities
One of the most effective ways to combat COVID-19 and mitigate its impact on high-risk populations is through community ...
Lupus Foundation of America2d
High-Dose BI655064 Shows Promising Results in Improving Renal Outcomes for People with Lupus Nephritis
In a new study, researchers evaluated the treatment effects of BI655064, an anti-CD40 monoclonal antibody, as an add-on ...
EurekAlert!5d
Breakthroughs in cell-penetrating monoclonal antibody therapies
mAbs have already changed the landscape of cancer therapy, offering treatments that ... pushes the boundaries by demonstrating how 3E10 antibodies can penetrate cells and access their internal ...
AZoLifeSciences on MSN3d
Advancements in Cell-Penetrating Antibodies Open New Avenues in Cancer Therapy
A news feature on the research paper "Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibition" ...
psypost.org on MSN6d
Neuroscientists just turned a major Alzheimer’s theory on its head
New research suggests Alzheimer's drugs may improve cognition by increasing Aβ42 levels rather than just reducing plaques, ...
News Medical6d
First-in-class monoclonal antibody shows promise for rare, aggressive hyperinflammatory condition
Adult patients with newly diagnosed malignancy-associated hemophagocytic lymphohistiocytosis (mHLH) – a rare, aggressive hyperinflammatory condition – who were treated with the first-in-class ...
EurekAlert!7d
ASH: Monoclonal antibody therapy improves survival in cancer-associated hyper-inflammatory disorder
Adult patients with newly diagnosed malignancy-associated hemophagocytic lymphohistiocytosis (mHLH) – a rare, aggressive hyperinflammatory condition – who were treated with the first-in-class ...